Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

March 4, 2025

Primary Completion Date

March 4, 2025

Study Completion Date

May 30, 2025

Conditions
Anus DiseasesGastrointestinal DiseasesIntestinal DiseasesCicatrizationHemorrhoidsHemorrhoids Third Degree
Interventions
DEVICE

Gel containing a Propionibacterium extract

Patients will apply 1 ml of gel (equal to one phalanx) twice a day for 20 days, manually at the anal level and in the perianal area. In the morning, after defecation and in the evening before going to bed.

DRUG

Hyaluronic acid and silver sulfadiazine

Patients will apply 1ml of gel (equal to a phalanx) twice a day for 20 days, manually at the anal level and in the perianal area. In the morning, after defecation and in the evening before going to bed.

Trial Locations (1)

09042

"Policlinico Universitario Monserrato Duilio Casula - AOU Cagliari", Monserrato

All Listed Sponsors
collaborator

Azienda Policlinico Umberto I

OTHER

collaborator

Hospital San Pietro Fatebenefratelli

OTHER

collaborator

University Hospital of Ferrara

OTHER

collaborator

ASL Roma 6

OTHER

lead

University of Cagliari

OTHER

NCT06872151 - Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study) | Biotech Hunter | Biotech Hunter